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Abstract
Purpose Use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as adjunct for temporary hemor-
rhage control in patients with exsanguinating torso hemorrhage is increasing. Characteristics of aortic occlusion balloons 
(AOB) are diverse and evolving as efforts are made to improve the technology. It is important to select a device that fits the 
requirements of the medical situation to minimize the risk of failure and complications. The aim of this study is to appraise 
guidance in the choice of an AOB in a specific situation.
Methods We assessed 29 AOB for differences and outline possible advantages and disadvantages of each. Bending stiffness 
was measured with a three-point bending device.
Results Diameter of the AOB ranged from 6 (ER-REBOA™) to 10  (Coda®-46) French. However, some need large-bore 
access sheaths up to 22 French  (Fogarty®-45 and  LeMaitre®-45) or even insertion via cut-down (Equalizer™-40). Bending 
stiffness varied from 0.08 N/mm (± 0.008 SD;  Coda®-32) to 0.72 N/mm (± 0.024 SD; Russian prototype). Rescue Balloon™ 
showed kinking of the shaft at low bending pressures. The only non-compliant AOB is REBOA  Balloon®. ER-REBOA™, 
 Fogarty®,  LeMaitre®, REBOA  Balloon®, and Rescue Balloon™ are provided with external length marks to assist blind 
positioning.
Conclusion In resource-limited settings, a guidewire- and fluoroscopy-free, rather stiff device, such as ER-REBOA™, 
 Fogarty®, and  LeMaitre®, is warranted. Of these devices, ER-REBOA™ is the only catheter compatible with seven French 
sheaths and specifically designed for emergency hemorrhage control. Of the over-the-wire devices,  Q50® has several features 
that facilitate use and reduce the risk of malplacement or vessel damage.
Keyword Aortic occlusion balloon catheter · REBOA · Resuscitation · Stiffness
Background
The use of Resuscitative Endovascular Balloon Occlusion of 
the Aorta (REBOA) as an adjunct for temporary hemorrhage 
control in patients with exsanguinating torso hemorrhage is 
increasing. In this technique, an occlusion balloon catheter 
is inserted, in most of the cases, into the femoral or brachial 
artery percutaneously or via surgical cut-down. It is then 
positioned into the aorta. There are two zones of occlusion, 
depending on the suspected site of injury. Zone I, between 
the left subclavian artery and the celiac trunk, is for the man-
agement of abdominal or retroperitoneal hemorrhage. Zone 
III occlusion, between the distal renal artery and the aortic 
bifurcation, is for the management of pelvic, junctional, or 
proximal lower extremity hemorrhage. Zone II, between the 
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celiac trunk and the distal renal artery, is considered as a 
zone of no occlusion [1–3]. By occluding the aorta above the 
level of injury, REBOA effectuates temporary distal hemor-
rhage control and centralizes blood flow. It thereby increases 
cardiac afterload and central aortic pressure, resulting in sus-
tained perfusion of the brain and heart [4–6].
There are a variety of aortic occlusion balloon catheters 
(AOB) available with different physical characteristics and 
specifications. Demands of the AOB differ depending on the 
indication for REBOA and the circumstances under which 
REBOA should be performed. The use of REBOA in the 
fields of trauma and maternal fetal medicine is increasing, 
thus, consequently, its use in relatively austere settings. 
Therefore, it is important to select a device that fits the 
demands of the situation to maximize success and reduce 
the risk of complications.
The aim of this study is to provide an overview of the 
commonly used AOB and their specifications, characteris-
tics, bending stiffness and possible advantages and disad-
vantages in their use to appraise guidance in the choice of 
an aortic occlusion balloon per medical situation.
Methods
In this review of available AOB, we assessed 29 AOB for 
differences, possible advantages and disadvantages based 
on current literature and experiences with REBOA. Con-
siderations for catheter characteristics will be discussed 
for different levels of care from resource-limited settings 
where real-time fluoroscopy is not readily available and 
other equipment resources may be limited, to more normal 
levels of care where fluoroscopy and other resources are 
commonly available.
Exclusion criteria
AOB from manufacturers or distributors that could not be 
reached or were not able or willing to provide a sample are 
excluded from this overview since inclusion would infer 
missing information that will lead to a disparate comparison.
Specifications
The AOB are assessed for dimensions of the catheter and 
balloon, material of the balloon, compatible introducer 
sheath and guidewire, number of lumina, tip design, radi-
opacity, features that ease balloon volume control and posi-
tioning, and other special features that ease handling of the 
AOB.
Bending stiffness
To quantify the bending stiffness (BS) of the AOB, we 
developed a three-point bending device (MK01-60, Fig. 1). 
The catheter is placed against two ball bearings and force is 
applied perpendicular to the longitudinal axis of the catheter 
midway between the ball bearings. The proximal and distal 
ends of the catheter can move freely when force is applied to 
eliminate frictional influence on the measured force. Force is 
applied and measured at multiple sites of the catheter shaft. 
Also, since most catheters are packaged rolled up and conse-
quently pre-curved, all catheters are measured in two direc-
tions (Fig. 2). The BS of the catheters is measured with and 
Fig. 1  Three-point bending device (MK01-60) for measuring catheter 
bending stiffness. The catheter is placed against the two ball bear-
ings and force is applied perpendicular to the longitudinal axis of the 
catheter midway between the ball bearings. The proximal and distal 
end of the catheter can move freely when force is applied. The force 
required to deflect the catheter 10  mm is measured with a digital 
force gauge
A contemporary assessment of devices for Resuscitative Endovascular Balloon Occlusion of…
1 3
without guidewire. Catheters without a supplied guidewire 
are measured with a standard 0.035 inch guidewire (Terumo 
(Tokyo, Japan)  Radifocus® Guidewire M Standard Type 
0.035′′, 150 cm).
The force (Newton) required to deflect the catheter 10 mm 
is measured with an ISO calibrated digital force gauge (PCE-
DFG N 10, PCE Instruments, Meschede, Germany) with a 
capacity of 0–10 N (N), a resolution of 0.005 N and an accu-
racy of 0.1% of full scale. The BS is expressed in N/mm. 
Also, the mean stiffness/French is calculated [N/(mm Fr)].
The test bench is validated by repeating 8/21 (38%) of 
the measurements at different times. All measurements are 
performed at room temperature (21 ± 0.4 °C).
Results
Twenty-nine AOB from ten different manufacturers were 
assessed for variables. Each of these manufacturers provided 
samples for physical examination. Tables 1 and 2 list the 
specifications and characteristics of the AOB from these 
manufacturers. The mean BS and stiffness/French of the 
obtained catheters is presented in Table 3.
Three AOB were excluded due to various reasons. This 
involved the ResQ™ Occlusion Balloon Catheter (QxMédi-
cal, Montreal, Quebec, Canada),  GORE® Molding & Occlu-
sion Balloon (W.L. Gore & Associates, Inc., Flagstaff, AZ, 
USA), and MIT aortic balloon (Minimally Invasive Tech-
nologies, Co. Ltd, Moscow, Russia). Reasons for not being 
able to include these AOB were: unable to reach the manu-
facturer, manufacturer was not able or willing to provide a 
sample or the (new) models were under development.
Aortic occlusion balloon catheters
Coda® Balloon Catheter (online resource 1)
Cook Medical, Bloomington, IN, USA, has an assortment of 
AOB with varying catheter and balloon sizes (Table 1). All 
catheters are double lumen. The Y-connector has indications 
for the balloon inflation port (“BALLOON”) and wire entry 
(“DISTAL”). The balloon port is provided with a stopcock 
for balloon volume control (Table 2).
The Coda-32-LP has a maximum balloon inflation diam-
eter of 32 mm. Its balloon length is 37 mm. The catheter is 
extremely flexible with a BS of 0.08 N/mm (± 0.008 SD) 
without guidewire and 0.11 N/mm (± 0.006 SD) with guide-
wire (Table 3).
The Coda-46 has a maximum balloon inflation diameter 
of 46 mm and a balloon length of 38 mm. It is slightly stiffer 
than the Coda-32-LP. Its BS is 0.12 N/mm (± 0.005 SD) 
without guidewire and 0.14 N/mm (± 0.010 SD) with guide-
wire (Table 3).
Equalizer™ Occlusion Balloon Catheter (online resource 2)
Boston Scientific, Marlborough, MA, USA, offers a wide 
range of the Equalizer™ Occlusion Balloon Catheter 
(Table 1). All catheters have two lumina. The balloon infla-
tion port is marked with “BALLOON” and has a different 
color than the catheter itself. The central guidewire lumen is 
marked with “DISTAL” and is shorter than the balloon infla-
tion port. The central lumen can also be used for infusion of 
contrast medium or medication. Both the balloon port and 
the central port have a luer-lock connector. There are no 
stopcocks pre-attached. The 40-mm balloon variants are not 
suitable for an introducer sheath, but have to be inserted bare 
via surgical cut-down. There are no length markings on the 
catheter shaft. According to the instructions for use (IFU), 
the catheter is designed for temporary vessel occlusion in 
various applications, including in patients requiring emer-
gency control of hemorrhage (Table 2). The catheter’s BS 
is 0.13 N/mm (± 0.032 SD) without guidewire and 0.16 N/
mm (± 0.025 SD) with guidewire (Table 3). The Equalizer™ 
Occlusion Balloon Catheters are supplied with a syringe.
Fig. 2  Measurement directions of the catheters. Situation A: force is 
applied in the direction of the curvature of the catheter. Situation B: 
force is applied in the opposite direction. The catheter is turned 180°. 
In case of straight catheters, the same procedure is followed
 S. M. Vrancken et al.
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Table 1  Specifications of aortic occlusion balloon catheters for REBOA
Aortic occlusion 
balloon
Max infla-
tion ∅ 
[mm]
Max inflation 
volume [mL]
Catheter ∅ 
[Fr]
Required intro-
ducer sheath
Compat-
ible GW ∅ 
[inch]
Length [cm] Lumina Tip
Coda® 2-9.0-35-
100-32, Cook 
Medical
32 30 9 12 Fr 0.035 100 2 Tapered flexible tip
Coda® 2-9.0-35-
120-32, Cook 
Medical
32 30 9 12 Fr 0.035 120 2 Tapered flexible tip
Coda® 2-10-35-
140-46, Cook 
Medical
46 60 10 14 Fr 0.035 140 2 Tapered flexible tip
Equalizer™ Occlu-
sion Balloon 
Catheter 17-105, 
Boston Scientific
20 4.8 7 14 Fr 0.038 65 2 Stiff tip
Equalizer™ Occlu-
sion Balloon 
Catheter 17-107, 
Boston Scientific
27 10 7 14 Fr 0.038 65 2 Stiff tip
Equalizer™ Occlu-
sion Balloon 
Catheter 17-109, 
Boston Scientific
33 19 7 16 Fr 0.038 65 2 Stiff tip
Equalizer™ Occlu-
sion Balloon 
Catheter 17-111, 
Boston Scientific
40 34.5 7 Via cut-down only 0.038 65 2 Stiff tip
Equalizer™ Occlu-
sion Balloon 
Catheter 17-106, 
Boston Scientific
20 4.8 7 14 Fr 0.038 100 2 Stiff tip
Equalizer™ Occlu-
sion Balloon 
Catheter 17-108, 
Boston Scientific
27 10 7 14 Fr 0.038 100 2 Stiff tip
Equalizer™ Occlu-
sion Balloon 
Catheter 17-110, 
Boston Scientific
33 19 7 16 Fr 0.038 100 2 Stiff tip
Equalizer™ Occlu-
sion Balloon 
Catheter 17-112, 
Boston Scientific
40 34.5 7 Via cut-down only 0.038 100 2 Stiff tip
ER-REBOA™, 
Prytime Medical 
Devices
32 24 6 7 Fr GW-free 72 2 Atraumatic P-tip™
Fogarty® Occlu-
sion Cath-
eter 62080814F, 
Edwards Lifes-
ciences
28 10 8 14 Fr GW-free 80 1 Soft flexible blunt 
tip
Fogarty® Occlu-
sion Cath-
eter 62080822F, 
Edwards Lifes-
ciences
45 43 8 22 Fr GW-free 80 1 Soft flexible blunt 
tip
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ER‑REBOA™ (online resource 3)
The ER-REBOA™ from Prytime Medical Devices, Boerne, 
TX, USA, is a 6-Fr, guidewire-free, double-lumen catheter 
(Table 1). The catheter shaft uses a concentric tube-in-tube 
design with inner elastic nitinol tube and outer plastic tube 
[7]. The inner lumen is used for arterial pressure monitoring 
with a pressure port distal from the balloon; the outer lumen 
is for balloon inflation. The ER-REBOA™ has an atraumatic 
P-tip™ designed to resist accidental entry into aortic side 
branches [7]. A peel-away sheath facilitates insertion of the 
catheter. The maximum balloon inflation diameter is 32 mm 
and the length of the balloon is 48 mm. The catheter shaft 
has external length marks every centimeter and indications 
of every 5 cm to facilitate placement in situations without 
fluoroscopy (Table 2). Both the balloon inflation port and 
the arterial pressure port of the Y-connector have a flexible 
extension with stopcock to facilitate balloon volume control 
AOB aortic occlusion balloon, cm centimeters, Fr French, GW guidewire, mL milliliters, mm millimeter
*Currently only available in the USA
Table 1  (continued)
Aortic occlusion 
balloon
Max infla-
tion ∅ 
[mm]
Max inflation 
volume [mL]
Catheter ∅ 
[Fr]
Required intro-
ducer sheath
Compat-
ible GW ∅ 
[inch]
Length [cm] Lumina Tip
LeMaitre® 
2107-80 Aortic 
Occlusion Cath-
eter, LeMaitre 
Vascular
28 15 8 14 Fr GW-free 80 1 Soft flexible blunt 
tip
LeMaitre® 
2107-81 Aortic 
Occlusion Cath-
eter, LeMaitre 
Vascular
45 50 8 22 Fr GW-free 80 1 Soft flexible blunt 
tip
Q50® Plus Q50-
65P, QXMédical 
(Merit Medical)
50 60 8 12 Fr 0.038 65 3 Tapered flexible tip
Q50® Plus Q50-
100P, QXMé-
dical (Merit 
Medical)
50 60 8 12 Fr 0.038 100 3 Tapered flexible tip
Q50X™ Q50-
65-X*, QXMé-
dical (Merit 
Medical)
50 60 8 10 Fr 0.038 65 3 Tapered flexible tip
Q50X™ Q50-
100-X*, QXMé-
dical (Merit 
Medical)
50 60 8 10 Fr 0.038 100 3 Tapered flexible tip
REBOA  Balloon® 
15, REBOA 
Medical AS
15 8 6 6 Fr 0.035 30/50/70 2 Stiff tapered tip
REBOA  Balloon® 
20, REBOA 
Medical AS
20 15 7 7 Fr 0.035 30/50/70 2 Stiff tapered tip
Reliant™ Stent 
Graft Bal-
loon Catheter, 
Medtronic
46 60 8 12 Fr 0.038 100 2 Stiff tapered tip
Rescue balloon™ 
OBS-01A, Tokai 
Medical Products
40 40 7 7 Fr 0.025 100 2 Flexible tip
Russian prototype 
AOB, Minimally 
Invasive Tech-
nologies
40 45 6 10 Fr GW-free 100 1 J-tip
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Table 2  Characteristics and features of aortic occlusion balloon catheters for REBOA
Aortic occlusion balloon Material Features Indications Price*
Coda® Balloon Catheter, Cook 
Medical
Compliant polyurethane Radiopaque markers at the bal-
loon to assist with positioning 
under fluoroscopy
Distinctive balloon port and 
central lumen port
Stopcock to facilitate balloon 
volume control
Temporary occlusion of large 
vessels
To expand vascular prostheses
€ 450
Equalizer™ Occlusion Balloon 
Catheter, Boston Scientific
Compliant natural rubber latex Radiopaque catheter shaft
Radiopaque markers at the bal-
loon to assist with positioning 
under fluoroscopy
Distinctive balloon port and 
central lumen port
Supplied with a syringe
Temporary occlusion of large 
vessels
Including emergency control of 
hemorrhage
€ 100
ER-REBOA™, Prytime Medical 
Devices
Compliant thermoplastic 
elastomer
Guidewire-free
External length marks every 
cm for positioning without 
fluoroscopy
Radiopaque catheter shaft
Radiopaque markers at the bal-
loon to assist with positioning 
under fluoroscopy
Pre-loaded peel-away sheath to 
ease insertion of the catheter’s 
P-tip™
Built-in arterial pressure lumen
Distinctive balloon port and 
central lumen port
Stopcock to facilitate balloon 
volume control
Available with convenience sets 
and access kits
Temporary occlusion of large 
vessels
Monitoring of blood pressure
Including emergency control of 
hemorrhage
€ 1950
Fogarty® Occlusion Catheter, 
Edwards Lifesciences
Compliant natural rubber latex Guidewire-free
Length marks every 10 cm to 
assist positioning without 
fluoroscopy
Radiopaque catheter shaft
Gate valve to facilitate balloon 
volume control
Temporary occlusion of large 
vessels
€ 155
LeMaitre® Aortic Occlusion 
Catheter, LeMaitre Vascular
Compliant natural rubber latex Guidewire-free
Length marks every 10 cm to 
assist positioning without 
fluoroscopy
Radiopaque catheter shaft
Stopcock to facilitate balloon 
volume control
Temporary occlusion of large 
vessels
€ 135
Q50® Stent Graft Balloon 
Catheter, QXMédical (Merit 
Medical)
Compliant polyurethane Three lumina to allow quick 
inflation and deflation of the 
balloon
Radiopaque markers at the bal-
loon to assist with positioning 
under fluoroscopy
Stopcock to facilitate balloon 
volume control
Temporary occlusion of large 
vessels
To expand vascular prostheses
€ 400
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and fluid control of the arterial line. The balloon arm has a 
white stopcock and indicates “BAL”. The arterial pressure 
port comes with a red stopcock and indicates “ART”. The 
BS of the catheter is 0.43 N/mm (± 0.013 SD) (Table 3).
The ER-REBOA™ is the most expensive catheter 
(Table 2). It is specifically designed for temporary hemor-
rhage control and resuscitation support in emergency set-
tings. Convenience sets and access kits are available contain-
ing materials needed for arterial access, sheath placement 
and fixation of the catheter.
Fogarty® Occlusion Catheter (online resource 4)
The  Fogarty® Occlusion Catheter from Edwards Lifes-
ciences, Irvine, CA, USA, comes in two models suitable 
for aortic occlusion (Table 1). Both catheters are single-
lumen, guidewire-free catheters with a blunt flexible tip. 
The catheters come with a removable stylet that increases 
body stiffness during placement of the catheter [BS 
0.25 ± 0.011 N/mm with stylet versus 0.12 ± 0.007 N/mm 
without stylet (Table 3)]. Marker bands assisting positioning 
without fluoroscopy are located on the catheter shaft every 
10 cm, decreasing in number and width towards the balloon 
(Table 2). The catheter shaft itself is radiopaque. It does 
not have distinct radiopaque marker bands at the balloon. A 
gate valve with luer-lock connector is attached to the proxi-
mal end of the catheter (the inflation port). Closing the gate 
valve prevents the balloon from deflation. The catheters are 
supplied in a straight tube and are therefore not pre-curved.
LeMaitre® Aortic Occlusion Catheter (online resource 5)
LeMaitre® Vascular, Burlington, MA, USA, offers two types 
of AOB suitable for REBOA (Table 1). Both models are 
guidewire-free, single-lumen catheters with an atraumatic 
flexible tip, and a two-way stopcock attached to the single 
lumen to maintain balloon inflation volume. Unique length 
markings are located on the catheter shaft every 10 cm to 
assist positioning without fluoroscopy (Table 2). There are 
no radiopaque marker bands located at the balloon; however, 
AOB aortic occlusion balloon, NA price information not yet available
*Approximate catalog price. Prices may vary based on regional differences, taxes, price agreements and changes over time
† Price for complete procedure kit. The balloon catheter is not sold separately
Table 2  (continued)
Aortic occlusion balloon Material Features Indications Price*
REBOA  Balloon®, REBOA 
Medical AS
Non-compliant thermoplastic 
elastomer
One or two length marks on the 
catheter shaft to assist posi-
tioning without fluoroscopy
Radiopaque markers at the bal-
loon to assist with positioning 
under fluoroscopy
Distinctive balloon port and 
central lumen port
Available with a complete 
kit containing all materials 
needed for REBOA
Temporary occlusion of the 
aorta
€1350†
Reliant™ Stent Graft Balloon 
Catheter, Medtronic
Compliant polyurethane Radiopaque markers at the bal-
loon to assist with positioning 
under fluoroscopy
Stopcock to facilitate balloon 
volume control
Temporary occlusion of large 
vessels
To expand vascular prostheses 
or assist in the expansion of 
self-expanding stent grafts
€ 180
Rescue balloon™, Tokai Medi-
cal Products
Compliant polyurethane Length marks every 5 cm to 
assist positioning without 
fluoroscopy
Radiopaque markers at the bal-
loon to assist with positioning 
under fluoroscopy
Stopcock to facilitate balloon 
volume control
Temporary occlusion of large 
vessels
Including emergency control of 
hemorrhage
NA
Russian prototype AOB, Mini-
mally Invasive Technologies
Latex Guidewire-free
Radiopaque catheter shaft
Stopcock to facilitate balloon 
volume control
Rubber ring that can indicate 
migration
Temporary occlusion of large 
vessels
NA
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the catheter shaft itself is radiopaque. The catheters are not 
pre-curved since they are supplied in a straight tube.
The  LeMaitre® 2107-80 has a maximum balloon inflation 
diameter of 28 mm and is compatible with a 14-Fr introducer 
sheath. The balloon length is approximately 20 mm. BS is 
0.33 N/mm (± 0.013 SD) (Table 3).
The  LeMaitre® 2107-81 has a maximum inflation diam-
eter of 45 mm and is compatible with a 22-Fr introducer 
sheath. Its balloon length is 24 mm. It has a BS of 0.33 N/
mm (± 0.017 SD) (Table 3).
Q50® Stent Graft Balloon Catheter (online resource 6)
QXMédical, Montreal, Quebec, Canada, manufactures four 
types of the  Q50® Stent Graft Balloon Catheter that are 
either compatible with a 12-Fr introducer sheath or a 10-Fr 
sheath (Table 1). The difference in introducer sheath com-
patibility is due to a different balloon wrapping of the  Q50® 
PLUS and the Q50X™. With a maximum balloon diameter 
of 50 mm, the  Q50® is the largest occlusion balloon. It has 
a length of approximately 40 mm. The  Q50® Stent Graft 
Table 3  Bending stiffness of aortic occlusion balloon catheters for REBOA
BS bending stiffness, Fr French, GW guidewire, mm millimeter, N Newton, n/a not applicable, SD standard deviation, w/ with, w/o without
Aortic occlusion 
balloon
Overall mean 
BS w/o GW [N/
mm] (± SD)
Mean BS/Fr 
w/o GW [N/
(mm Fr)]
Overall mean 
BS w/ GW [N/
mm] (± SD)
Mean BS/Fr w/ 
GW [N/(mm 
Fr)]
Overall mean 
BS w/ stylet [N/
mm] (± SD)
Mean BS/Fr w/ 
stylet [N/(mm 
Fr)]
Guidewire
Coda-2-9.0-35-
120-32
0.08 (± 0.008) 0.009 0.11 (± 0.006) 0.012 n/a n/a Terumo 
 Radifocus® 
Guidewire M 
Standard Type 
0.035′′
Coda-2-10-35-
140-46
0.12 (± 0.005) 0.012 0.14 (± 0.010) 0.014 n/a n/a Terumo 
 Radifocus® 
Guidewire M 
Standard Type 
0.035′′
Equalizer™ 
17-109
0.13 (± 0.032) 0.019 0.16 (± 0.025) 0.023 n/a n/a Terumo 
 Radifocus® 
Guidewire M 
Standard Type 
0.035′′
ER-REBOA™ 0.43 (± 0.013) 0.071 n/a n/a n/a n/a n/a
Fogarty® 
62080814F
0.12 (± 0.007) 0.015 n/a n/a 0.25 (± 0.011) 0.031 n/a
LeMaitre® 
2107-80
0.33 (± 0.013) 0.041 n/a n/a n/a n/a n/a
LeMaitre® 
2107-81
0.33 (± 0.017) 0.042 n/a n/a n/a n/a n/a
Q50® Plus Q50-
65P
0.30 (± 0.061) 0.037 0.34 (± 0.043) 0.042 n/a n/a Terumo 
 Radifocus® 
Guidewire M 
Standard Type 
0.035′′
REBOA 
 Balloon® 20
0.17 (± 0.036) 0.024 0.30 (± 0.040) 0.042 n/a n/a SP Medical 
Accoat Guide 
Wire Seldinger 
Extra stiff, 
0.035′′
Reliant™ 0.11 (± 0.016) 0.014 0.14 (± 0.017) 0.017 n/a n/a Terumo 
 Radifocus® 
Guidewire M 
Standard Type 
0.035′′
Rescue bal-
loon™
0.23 (± 0.048) 0.032 0.26 (± 0.051) 0.038 0.47 (± 0.036) 0.067 Hydrophilic GW 
0.025′′
Russian proto-
type
0.72 (± 0.024) 0.119 n/a n/a n/a n/a n/a
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Balloon Catheters are the only AOB with three lumina. It 
has two balloon inflation lumina to allow quick inflation and 
deflation of the balloon. The third lumen is intended for a 
guidewire. The balloon inflation port has an extension tube 
with a stopcock to prevent balloon deflation (Table 2).  Q50® 
distributor Merit Medical (South Jordan, UT, USA) offers 
a lockable syringe  (VacLok® Negative Pressure Syringe) to 
facilitate balloon volume control. BS is 0.30 N/mm (± 0.061 
SD) without guidewire and 0.34 N/mm (± 0.043 SD) with 
guidewire (Table 3).
REBOA  Balloon® (online resource 7)
REBOA Medical AS, Norway, offers a broad range of the 
REBOA  Balloon® catheter (Table 1). It is the only AOB 
with a non-compliant balloon. It consists of a thermoplastic 
elastomer (DEHP free and latex free). The maximum diam-
eter of the balloon with standard injection volume avoids 
aortic wall rupture since over-inflation is not possible. How-
ever, it does impose a risk of rupturing the aorta in patients 
with a smaller aortic diameter. In situations where the aortic 
diameter is in excess of the occlusion balloon diameter, the 
balloon will not provide occlusion or hemorrhage control.
The REBOA Medical AS balloon catheters are available 
with a 15-mm (6-Fr) or 20-mm (7-Fr) balloon diameter The 
catheters can only be ordered as a complete kit containing 
all materials needed for REBOA, including a guidewire (SP 
Medical Accoat Guide Wire Seldinger Extra stiff, J3 mm 
tip, PTFE coated, 150-cm length, 0.035-inch diameter). The 
catheters have a coaxial double-lumen design. The balloon 
inflation port is marked with “BALLOON” and is longer, 
and has a different color than the guidewire lumen (Table 2). 
According to the IFU, the catheters can be placed without 
fluoroscopic guidance. To aid positioning without fluoros-
copy, the 50-cm catheters have a shaft marking at 30 cm 
from the distal tip. The 70-cm catheters have single line 
marking at 30 cm from the distal tip and a double line at 
50 cm from the distal tip. The BS of the 7-Fr catheter is 
0.17 N/mm (± 0.036 SD) without guidewire and 0.30 N/mm 
(± 0.040 SD) with guidewire (Table 3).
Reliant™ Stent Graft Balloon Catheter (online resource 8)
The Reliant™ Stent Graft Balloon Catheter from Medtronic, 
Minneapolis, MN, USA, is a flexible double-lumen catheter 
with a BS of 0.11 N/mm (± 0.016 SD) without guidewire 
and 0.14 N/mm (± 0.017 SD) with guidewire (Table 3). The 
balloon has a maximum inflation diameter of 46 mm and 
a length of approximately 37 mm (Table 1). There are no 
length markings on the catheter shaft. The balloon inflation 
port of the Y-connector has a flexible extension with a three-
way stopcock to assist in balloon volume control (Table 2).
Rescue Balloon™ (online resource 9)
The Tokai Rescue Balloon™ OBS-01A from Tokai Medi-
cal Products, Aichi, Japan, is a small-sized, double-lumen 
7-Fr catheter (Table 1). It can be used with a 0.025-inch 
guidewire that is provided with the catheter. After balloon 
positioning, the guidewire can be removed and a stylet 
can be inserted to provide additional catheter stiffness [BS 
0.47 ± 0.036 N/mm with stylet versus 0.26 ± 0.051 N/mm 
with guidewire (Table 3)]. The BS of the catheter is 0.23 N/
mm (± 0.048 SD). Length marks that assist with positioning 
without fluoroscopy are located on the catheter shaft every 
5 cm (Table 2). A double mark is located 55 cm from the 
tip of the catheter. The balloon inflation port has a flexible 
extension with a stopcock to prevent deflation of the balloon 
during the procedure.
The catheter tends to kink and when kinked, it remains 
plastically deformed. Careful handling of the catheter to pre-
vent kinking prior to insertion is important.
Russian prototype aortic occlusion balloon (online resource 
10)
The Russian prototype AOB from Minimally Invasive Tech-
nologies, Co. Ltd, Moscow, Russia, is a small-sized 6-Fr 
catheter (Table 1). The deflated balloon requires a 10-Fr 
sheath. Despite the small diameter, it is the stiffest cath-
eter with a BS of 0.72 N/mm (± 0.024 SD) (Table 3). The 
maximum inflation diameter of the balloon is 40 mm and its 
length is approximately 34 mm. The catheter has a built-in 
J-tip guidewire which cannot be removed from the catheter. 
It also has a rubber stop ring that can be used to indicate 
initial introduction depth and possible subsequent migra-
tion of the catheter (Table 2). There are no length markings 
on the catheter shaft. The transition from catheter shaft to 
guidewire tip is visible with fluoroscopy.
Discussion
There is a wide variety of AOB available and specifications, 
and characteristics are diverse. With the increasing use of 
REBOA in the field of trauma, maternal fetal medicine and 
iatrogenic surgical hemorrhage, it is important to choose a 
device that fits the demands for the best success rate for a 
patient in need of urgent hemorrhage control. However, there 
is no consensus on the desired specific features of the AOB. 
This article provides an overview of the currently available 
AOB with their specifications, characteristics and bending 
stiffness, and possible advantages and disadvantages in their 
use after extensive review of the catheters. Cautious recom-
mendations for selecting an AOB are done based on this 
review, current literature and experience with REBOA.
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Only three AOB, the Equalizer™, ER-REBOA™, and 
Rescue balloon™ have specifically indicated in their IFU 
that it is intended for use in patients with massive bleeding. 
Suitability for partial aortic occlusion is not described in 
any of the IFUs. All catheters are small caliber catheters. 
Required introducer sheath size and the catheters BS, how-
ever, vary widely. We found that the guidewire-free devices 
are generally stiffer than the over-the-wire catheters and a 
standard guidewire only adds minimal extra stiffness. Cath-
eter stiffness, including a stiff catheter tip, might increase the 
risk of dissection or rupture of the aorta during placement 
[8]. On the other hand, Onishi et al. described a case of a 
loop formation of an AOB in the aorta presumably due to 
a more flexible small caliber catheter [9]. Borger van der 
Burg et al. also demonstrates an association between catheter 
stiffness and migration of the aortic occlusion balloon [10]. 
In their study, minor primary migration during insufflation 
is observed in all devices. Only the Cook  Coda® Balloon 
Catheter and the Russian prototype AOB showed subsequent 
migration under higher pressures. Comparing these findings 
with our results, we can conclude that the most flexible and 
the stiffest catheters migrated while fully inflated, suggesting 
there is an optimum in catheter stiffness regarding the risk 
of balloon migration. The stiff catheter (Russian prototype 
AOB, BS 0.72 N/mm (± 0.024 SD)) showed outward migra-
tion at the sheath; while, migration of the highly flexible 
catheters (9 Fr  Coda® with BS of 0.08 N/mm (± 0.008 SD) 
and 10-Fr  Coda® with BS of 0.012 N/mm (± 0.005 SD)) 
was due to kinking of the catheter in the aorta which was 
not visible at the sheath. Theoretically, outward migration or 
kinking of the catheter is also possible in patients in whom 
restoration of blood pressure leads to an increase in aortic 
diameter and consequently loss of contact surface between 
the balloon and aortic wall, while downward pressure on 
the catheter is increasing. By general rules, the axial force 
a catheter can resist is limited by the buckling force. The 
buckling force depends on the BS as well as the aspect ratio 
(relation between length, area, and moment of inertia) of 
the catheter. A catheter with a high BS is more resistant to 
kinking due to in vivo axial pressure. However, the buck-
ling force of most catheters will be negligible due to the 
large aspect ratio. The flexible Reliant™ catheter (BS 0.11 
(± 0.016 SD)) did not show secondary migration in the study 
of Borger van der Burg et al. This supports the theory that 
frictional force between the balloon and aortic wall is of 
importance in preventing migration or kinking of the cath-
eter. Despite the observed migration, all catheters achieved 
total aortic occlusion and can be used for REBOA. However, 
in vivo kinking of the catheter shaft can lead to an improper 
occlusion location when fluoroscopy is not available to con-
firm the position of the balloon [9–11]. In resource-limited 
settings where real-time fluoroscopy is not readily avail-
able, such as the obstetrics delivery room, intensive care 
unit, remote areas (such as military treatment facilities) or 
out-of-hospital REBOA, catheters with medium to high stiff-
ness are, therefore, a safer option. These include the ER-
REBOA™,  LeMaitre®, or  Fogarty® with stylet. Obtaining 
plain radiographs directly before and after balloon inflation 
to confirm balloon position can be an alternative for fluoro-
scopic guidance. However, real-time fluoroscopic guidance 
is always preferred to monitor possible migration or over-
inflation with consequent rupture of the balloon or aorta.
In environments with limited equipment resources or sup-
porting staff that are not familiar with endovascular mate-
rials, the complete procedure kits from REBOA Medical 
AS (REBOA  Balloon®) or Prytime Medical Devices (ER-
REBOA™) are beneficial. When considering health care 
costs as limited resource barrier, the ER-REBOA™ (approx-
imately 1950 euro) can be a barrier, especially in middle- to 
low-income countries. To explore the need for REBOA in 
such countries, we are currently preparing a study into non-
compressible truncal hemorrhage in the Republic of South 
Africa (RSA), one of such countries with a high trauma 
caseload. Through an international collaborative program 
[12], we have already used REBOA in several trauma cases 
in the RSA over the last years.
Our results provide evidence that a standard guide-
wire only adds minimal extra stiffness to the catheter, so 
this should not be an argument to choose an over-the-wire 
device. Moreover, guidewire-free devices itself are generally 
stiffer than the over-the-wire catheters and are provided with 
a flexible atraumatic tip to prevent aortic punctures. With the 
advent of REBOA-specific devices that house features of 
wire stiffness within the catheter, it is no longer advisable to 
use over-the-wire catheters for REBOA in emergency situa-
tions, especially those in which real-time fluoroscopy is not 
available. When fluoroscopy is available, an over-the-wire 
device can be considered to aid and confirm correct posi-
tioning, especially in middle-aged and elderly patients in 
whom tortuosity of blood vessels is more prevalent. REBOA 
via brachial artery access should not be performed without 
guidewire and fluoroscopic guidance given the higher risk of 
misplacement of the catheter. Of the over-the-wire devices, 
the  Q50® has several features that facilitate use and reduce 
the risk of malplacement or vessel damage (medium stiff, 
sufficient balloon diameter, flexible tip), especially when 
combined with the  VacLok® syringe.
The tested catheters are small caliber catheters ranging 
from 6 to 10 Fr. Required introducer sheath size, however, 
varies from 6 to 22 Fr with the  LeMaitre® 45 mm Aortic 
Occlusion Catheter and Edwards  Fogarty® 62080822F 
Occlusion Catheter, or even insertion via surgical cut-down 
only (Boston Scientific Equalizer™ with 40 mm balloon). 
The difference in catheter diameter and required sheath size 
is due to a larger diameter of the balloon or balloon wrap-
ping, or to an increased balloon diameter after inflation and 
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deflation of the devices. Devices compatible with a small 
introducer sheath are the ER-REBOA™ (7 Fr), Tokai Res-
cue Balloon™ (7 Fr), and REBOA Medical AS REBOA 
 Balloon® 15 and 20 (6 Fr and 7 Fr, respectively). It is known 
that larger sheath sizes require either surgical repair of the 
access site after sheath removal or access site closure with a 
large-bore vascular closure device (VCD), while the smaller 
ones can be removed without surgical repair. Percutaneous 
access and access site closure might be elegant considering 
it reduces wound complications at the access site [13, 14]. 
Also, femoral access site complications, such as dissection, 
pseudo-aneurysm, embolism or limb ischemia are associated 
with the larger sheath sizes [15, 16]; whereas, Teeter et al. 
[17] describe no access-related complications in their series 
with 7-Fr introducer sheaths. Hence, in the era of new, small 
diameter REBOA-specific devices, it is no longer advisable 
to use a catheter larger than 7 Fr to perform this procedure 
in emergent situations, especially those in which vascular 
surgery consultation is not readily available. Furthermore, 
some large-bore VCDs such as the Perclose  Proglide® and 
Prostar  XL® (Abbott Vascular, Santa Clara, CA, USA) or 
the MANTA™ VCD (Teleflex Incorporated, Wayne, PA, 
USA) predominantly require either a preclose technique or 
pre-procedural depth measurement, thereby increasing time 
to vascular access, while early and quick vascular access 
and bleeding control is essential to improve outcome of the 
hemorrhagic trauma patient. The InClosure VCD (InSeal 
Medical, Caesarea, Israel) and PerQseal (Vivasure Medical, 
Galway Ireland) do not require any preparation before the 
main procedure. With the smaller sheath sizes, the femoral 
artery puncture site can be closed either with direct pres-
sure or with an Angio-Seal™ (up to 8 Fr; Terumo, Tokyo, 
Japan) or  EXOSEAL® or  MYNXGRIP® (up to 7 Fr; Cordis, 
Santa Clara, CA, USA). These VCDs do not require any pre-
procedural preparations. Khan et al. described an alternative 
route for vascular access [18]. In their case, the aorta was 
punctured directly to place an ER-REBOA™ during lapa-
rotomy of a patient in extremis from multicavity penetrating 
trauma. With this hybrid approach quick vascular access is 
achieved without making unnecessary additional wounds. 
Their technique was successful in achieving hemodynamic 
stability.
Another feature that has to be taken into account is the 
balloon diameter. Maximum balloon diameter of the devices 
varies from 15 mm (REBOA  Balloon® 15) to 50 mm  (Q50® 
Stent Graft Balloon Catheter). The diameter of the occlu-
sion balloon must be sufficient for total aortic occlusion, 
considering a smaller diameter is required for zone III occlu-
sion than for zone I occlusion. Since most catheters carry 
a compliant balloon, the larger balloon diameters are also 
suitable for smaller aortic diameters. The REBOA  Balloon® 
from REBOA Medical AS is the only device with a non-
compliant balloon. Since non-compliant balloons have 
standard injection volumes, it may avoid over-inflation and 
subsequent rupture of the balloon or aortic wall. However, 
if the diameter of the aorta is smaller than the diameter of 
the non-compliant balloon, the balloon can create a tear in 
the aortic wall [19]. Furthermore, when the diameter of the 
aorta exceeds the diameter of the non-compliant balloon, no 
proper hemorrhage control will be established. The choice 
for a compliant or non-compliant balloon should be carefully 
considered based on the possible advantages and disadvan-
tages and preference of the providing physician. Profound 
data on balloon material properties, such as compliance and 
the frictional properties of balloon surface, are missing and 
should be a topic of interest in the development of new, 
REBOA-specific devices.
All catheters have features that ease correct positioning. 
When fluoroscopy is available, radiopaque marker bands 
located at the balloon assist in positioning of the balloon. 
Especially, markers at the distal and proximal end of the 
balloon are helpful to visualize the proper inflation loca-
tion. Catheters without markers located at the balloon but 
with a completely radiopaque catheter shaft are also helpful 
in positioning the balloon, assuming the balloon is near the 
distal end of the catheter. However, the exact occlusion zone 
cannot be confirmed unless balloon inflation occurs with a 
contrast medium. Consequently, inflation could occur in or 
overlapping the wrong aortic zone.
When fluoroscopy is not available, as in out-of-hospital 
REBOA or other resource-limited settings, devices with 
external length marks on the catheter shaft enable correct 
positioning of the balloon without imaging. Placement 
depths can be estimated before insertion of the catheter 
using anatomical landmarks such as the suprasternal notch, 
mid-sternum, xiphoid process or umbilicus [20, 21]. The 
ER-REBOA™ facilitates accurate positioning with a length 
mark every cm and the exact length indicated with num-
bers every 5 cm. The Tokai Rescue Balloon™,  LeMaitre® 
Aortic Occlusion Catheters and Edwards  Fogarty® Occlu-
sions Catheters have length marks every 5 or 10 cm to assist 
positioning without fluoroscopy. The REBOA  Balloon® 
has length marks at 30 and 55 cm to allow a standardized 
placement depth. It thereby might reduce procedure time. 
Standardized placement depth and the use of anatomical 
landmarks are based on average body measures from pre-
dominantly low-volume studies [20–24]. It may, however, 
lead to inadequate balloon positioning in an unknown num-
ber of patients. Therefore, future research should focus on 
further objectifying these population-based average body 
measures to help reduce the chance of improper balloon 
positioning in the field.
There are limitations in this study. The bending stiffness 
of the catheters is measured at room temperature and not at 
body temperature. Material properties may alter in higher 
temperatures; thus, bending stiffness might differ at body 
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temperature. However, room temperature lies within the 
temperature range indicated on the catheters. In vivo lon-
gitudinal or axial stiffness can also be important; whereas 
in our study, bending stiffness was measured perpendicu-
larly. However, the axial force from the catheter on the 
inflated balloon is in most cases negligible compared to 
the friction force between balloon and the inner wall of 
the artery, because of the large aspect ratio of the catheter. 
Also, a number of AOB are missing from this overview 
due to various reasons. To avoid a disparate comparison 
due to missing information, we chose to exclude these 
AOB. In addition, some of the devices might not be avail-
able in all countries due to regulatory restrictions.
Conclusion
Although there is a wide variety of AOB available, in 
resource-limited settings, a medium-stiff to stiff device that 
can be placed without guidewire and fluoroscopy guidance 
is warranted. Catheters such as the ER-REBOA™,  Fogarty®, 
and  LeMaitre® are, therefore, advised. Of these devices, the 
ER-REBOA™ is the only catheter compatible with a small 
7-Fr sheath and specifically designed for hemorrhage con-
trol in emergent settings and should, therefore, be preferred. 
Complete procedure kits for the REBOA  Balloon® or ER-
REBOA™ are beneficial, especially in environments with 
limited equipment resources. When fluoroscopy is available, 
an over-the-wire device should be considered to aid and con-
firm correct positioning. Of the over-the-wire devices, the 
 Q50® has several features that facilitate use and reduce the 
risk of malplacement or vessel damage.
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